Logo image of SMLR

SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis

NASDAQ:SMLR - Nasdaq - US81684M1045 - Common Stock - Currency: USD

32.485  +1.48 (+4.79%)

After market: 34.1631 +1.68 (+5.17%)

Fundamental Rating

7

Overall SMLR gets a fundamental rating of 7 out of 10. We evaluated SMLR against 190 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making SMLR a very profitable company, without any liquidiy or solvency issues. SMLR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make SMLR a good candidate for value investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

SMLR had positive earnings in the past year.
In the past year SMLR had a positive cash flow from operations.
SMLR had positive earnings in each of the past 5 years.
SMLR had a positive operating cash flow in each of the past 5 years.
SMLR Yearly Net Income VS EBIT VS OCF VS FCFSMLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

SMLR's Return On Assets of 17.05% is amongst the best of the industry. SMLR outperforms 96.86% of its industry peers.
The Return On Equity of SMLR (17.72%) is better than 93.72% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.66%, SMLR belongs to the top of the industry, outperforming 85.34% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SMLR is significantly above the industry average of 7.68%.
The last Return On Invested Capital (7.66%) for SMLR is well below the 3 year average (20.14%), which needs to be investigated, but indicates that SMLR had better years and this may not be a problem.
Industry RankSector Rank
ROA 17.05%
ROE 17.72%
ROIC 7.66%
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
SMLR Yearly ROA, ROE, ROICSMLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

With an excellent Profit Margin value of 72.65%, SMLR belongs to the best of the industry, outperforming 98.43% of the companies in the same industry.
In the last couple of years the Profit Margin of SMLR has grown nicely.
With an excellent Operating Margin value of 37.19%, SMLR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of SMLR has grown nicely.
With an excellent Gross Margin value of 91.54%, SMLR belongs to the best of the industry, outperforming 98.95% of the companies in the same industry.
SMLR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 37.19%
PM (TTM) 72.65%
GM 91.54%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
SMLR Yearly Profit, Operating, Gross MarginsSMLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

SMLR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for SMLR has been increased compared to 1 year ago.
SMLR has more shares outstanding than it did 5 years ago.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SMLR Yearly Shares OutstandingSMLR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SMLR Yearly Total Debt VS Total AssetsSMLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

SMLR has an Altman-Z score of 21.80. This indicates that SMLR is financially healthy and has little risk of bankruptcy at the moment.
SMLR's Altman-Z score of 21.80 is amongst the best of the industry. SMLR outperforms 97.38% of its industry peers.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.8
ROIC/WACC0.85
WACC8.98%
SMLR Yearly LT Debt VS Equity VS FCFSMLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 3.59 indicates that SMLR has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.59, SMLR is doing good in the industry, outperforming 64.40% of the companies in the same industry.
SMLR has a Quick Ratio of 3.54. This indicates that SMLR is financially healthy and has no problem in meeting its short term obligations.
SMLR has a better Quick ratio (3.54) than 70.16% of its industry peers.
Industry RankSector Rank
Current Ratio 3.59
Quick Ratio 3.54
SMLR Yearly Current Assets VS Current LiabilitesSMLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.82% over the past year.
Measured over the past years, SMLR shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.17% on average per year.
The Revenue for SMLR has decreased by -17.46% in the past year. This is quite bad
Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)101.82%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%477.97%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-17.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-67.65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SMLR Yearly Revenue VS EstimatesSMLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SMLR Yearly EPS VS EstimatesSMLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.85 indicates a rather cheap valuation of SMLR.
Based on the Price/Earnings ratio, SMLR is valued cheaper than 97.91% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, SMLR is valued rather cheaply.
With a Price/Forward Earnings ratio of 18.10, SMLR is valued on the expensive side.
SMLR's Price/Forward Earnings ratio is rather cheap when compared to the industry. SMLR is cheaper than 82.20% of the companies in the same industry.
SMLR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.08.
Industry RankSector Rank
PE 5.85
Fwd PE 18.1
SMLR Price Earnings VS Forward Price EarningsSMLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

SMLR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SMLR is cheaper than 82.20% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SMLR is valued cheaper than 91.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.8
EV/EBITDA 13.52
SMLR Per share dataSMLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The excellent profitability rating of SMLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.24
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SMLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SEMLER SCIENTIFIC INC

NASDAQ:SMLR (4/17/2025, 8:00:02 PM)

After market: 34.1631 +1.68 (+5.17%)

32.485

+1.48 (+4.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)05-13 2025-05-13
Inst Owners59.49%
Inst Owner Change-0.25%
Ins Owners7.49%
Ins Owner Change2.96%
Market Cap311.86M
Analysts82.86
Price Target72.42 (122.93%)
Short Float %21.05%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)831.17%
Min EPS beat(2)90.78%
Max EPS beat(2)1571.57%
EPS beat(4)3
Avg EPS beat(4)412.16%
Min EPS beat(4)-25.76%
Max EPS beat(4)1571.57%
EPS beat(8)7
Avg EPS beat(8)217.23%
EPS beat(12)10
Avg EPS beat(12)153.66%
EPS beat(16)12
Avg EPS beat(16)114.37%
Revenue beat(2)2
Avg Revenue beat(2)1.26%
Min Revenue beat(2)1.12%
Max Revenue beat(2)1.39%
Revenue beat(4)2
Avg Revenue beat(4)-6.19%
Min Revenue beat(4)-27.14%
Max Revenue beat(4)1.39%
Revenue beat(8)6
Avg Revenue beat(8)-0.14%
Revenue beat(12)7
Avg Revenue beat(12)-1%
Revenue beat(16)9
Avg Revenue beat(16)-1.22%
PT rev (1m)0%
PT rev (3m)77.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.85
Fwd PE 18.1
P/S 5.54
P/FCF 12.8
P/OCF 12.78
P/B 1.35
P/tB 19.35
EV/EBITDA 13.52
EPS(TTM)5.55
EY17.08%
EPS(NY)1.8
Fwd EY5.53%
FCF(TTM)2.54
FCFY7.81%
OCF(TTM)2.54
OCFY7.83%
SpS5.86
BVpS24.04
TBVpS1.68
PEG (NY)N/A
PEG (5Y)0.24
Profitability
Industry RankSector Rank
ROA 17.05%
ROE 17.72%
ROCE 8.96%
ROIC 7.66%
ROICexc 8.18%
ROICexgc 451.14%
OM 37.19%
PM (TTM) 72.65%
GM 91.54%
FCFM 43.27%
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexcg growth 3Y32.01%
ROICexcg growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 8.81%
Cap/Sales 0.09%
Interest Coverage 250
Cash Conversion 113.47%
Profit Quality 59.56%
Current Ratio 3.59
Quick Ratio 3.54
Altman-Z 21.8
F-Score4
WACC8.98%
ROIC/WACC0.85
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)101.82%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%477.97%
EPS Next Y-67.65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-17.57%
Revenue Next Year1.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.97%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year8.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.81%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y14.44%
OCF growth 3Y14.98%
OCF growth 5Y13.91%